These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 17056092

  • 1. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update.
    Ordóñez NG.
    Hum Pathol; 2007 Jan; 38(1):1-16. PubMed ID: 17056092
    [Abstract] [Full Text] [Related]

  • 2. Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update.
    Ordóñez NG.
    Adv Anat Pathol; 2006 Jan; 13(1):16-25. PubMed ID: 16462153
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.
    Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K.
    Pathol Int; 2007 Apr; 57(4):190-9. PubMed ID: 17316414
    [Abstract] [Full Text] [Related]

  • 4. Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
    Ordóñez NG.
    Hum Pathol; 2013 Jan; 44(1):1-19. PubMed ID: 22963903
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW, Koivurinne K.
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical diagnosis of epithelioid mesothelioma: an update.
    Ordóñez NG.
    Arch Pathol Lab Med; 2005 Nov; 129(11):1407-14. PubMed ID: 16253021
    [Abstract] [Full Text] [Related]

  • 9. Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases.
    Moran CA, Albores-Saavedra J, Suster S.
    Histopathology; 2008 Jun; 52(7):824-30. PubMed ID: 18494612
    [Abstract] [Full Text] [Related]

  • 10. Re: Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.
    Tutar E.
    Pathol Int; 2009 Apr; 59(4):274; author reply 274. PubMed ID: 19351375
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin.
    Padgett DM, Cathro HP, Wick MR, Mills SE.
    Am J Surg Pathol; 2008 Jan; 32(1):123-7. PubMed ID: 18162779
    [Abstract] [Full Text] [Related]

  • 13. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
    Ordóñez NG.
    Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study.
    Ordóñez NG, Sahin AA.
    Hum Pathol; 2014 Jul; 45(7):1529-40. PubMed ID: 24816068
    [Abstract] [Full Text] [Related]

  • 15. Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma.
    Amatya VJ, Takeshima Y, Kohno H, Kushitani K, Yamada T, Morimoto C, Inai K.
    Histopathology; 2009 Jul; 55(1):10-9. PubMed ID: 19614762
    [Abstract] [Full Text] [Related]

  • 16. Podoplanin: a novel diagnostic immunohistochemical marker.
    Ordóñez NG.
    Adv Anat Pathol; 2006 Mar; 13(2):83-8. PubMed ID: 16670463
    [Abstract] [Full Text] [Related]

  • 17. Expression of podoplanin and calretinin in meningioma: an immunohistochemical study.
    Shintaku M, Honda T, Sakai T.
    Brain Tumor Pathol; 2010 Apr; 27(1):23-7. PubMed ID: 20425044
    [Abstract] [Full Text] [Related]

  • 18. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma.
    Suster S, Moran CA.
    Adv Anat Pathol; 2006 Nov; 13(6):316-29. PubMed ID: 17075297
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.